(Q38322168)

2 September 2017

title

Development and characterization of an aptamer binding ligand of fractalkine using domain targeted SELEX. (English)

1 reference

2 September 2017

Efrosini Kokkoli

5

0 references

Srinand Sreevatsan

object named as

Srinand Sreevatsan

4

0 references

author name string

Brett Waybrant

1

1 reference

2 September 2017

Timothy R Pearce

2

1 reference

2 September 2017

Ping Wang

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

2 September 2017

published in

Chemical Communications

1 reference

2 September 2017

volume

48

1 reference

2 September 2017

issue

80

1 reference

2 September 2017

page(s)

10043-10045

1 reference

Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

A new class of membrane-bound chemokine with a CX3C motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

Fractalkine in rheumatoid arthritis: a review to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

CX3CL1 in allergic diseases: not just a chemotactic molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

Fractalkine targeting with a receptor-mimicking peptide-amphiphile

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

Targeting cancer cells with nucleic acid aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

An improved method for the in vitro evolution of aptamers and applications in protein detection and purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34217K

21 January 2018

Identifiers

DOI

10.1039/C2CC34217K

1 reference

2 September 2017

1 reference